Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-19 · accession 0001628280-26-020574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 2026-03-19 | BLFS | Mathew Aby J. | EVP, CSO | F - Tax | $19.12 | -2,255 | 390.7K | -0.6% | -$43.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-19 | F | D | 2,255 | $19.12 | 390,682 | D | — | — | (F1) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |